Brief: SenesTech Inc Says Has Been Working With TriptoBIO On Development Of Biosynthetic Triptolide
14/03/2023 13:20
March 14 (Reuters) - SenesTech Inc SNES.O :
* SENESTECH INC - HAS BEEN WORKING WITH TRIPTOBIO ON
DEVELOPMENT
OF BIOSYNTHETIC TRIPTOLIDE, ONE OF ACTIVE INGREDIENTS IN
CONTRAPEST
Source text for Eikon: ID:nPn3TZBMma
Further company coverage: SNES.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SenesTech
See all newsBrief: Senestech Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Senestech Inc reports results for the quarter ended June 30 - Earnings Summary
SenesTech Q2 revenue jumps on e-commerce growth
Brief: SenesTech Q2 Revenue USD 770 Thousand
Senestech Inc expected to post a loss of 36 cents a share - Earnings Preview